Bio-Rad Laboratories (BIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Sales | 2,671,262 | 2,802,249 | 2,922,545 | 2,545,626 | 2,311,659 |
| Cost of Goods | 1,244,316 | 1,234,919 | 1,284,449 | 1,107,739 | 1,054,663 |
| Gross Profit | 1,426,946 | 1,567,330 | 1,638,096 | 1,437,887 | 1,256,996 |
| Operating Expenses | 1,089,466 | 1,085,633 | 1,138,209 | 1,017,300 | 1,027,998 |
| Operating Income | 337,796 | 482,616 | 500,336 | 421,326 | 229,661 |
| Interest Expense | 49,439 | 38,114 | 1,551 | 21,861 | 23,416 |
| Other Income | -1,138,461 | -5,148,775 | 4,950,270 | 4,518,542 | 2,054,836 |
| Pre-tax Income | -850,104 | -4,704,273 | 5,449,055 | 4,918,007 | 2,261,081 |
| Income Tax | -212,780 | -1,076,738 | 1,194,798 | 1,103,778 | 502,406 |
| Net Income Continuous | -637,324 | -3,627,535 | 4,254,257 | 3,814,229 | 1,758,675 |
| Net Income | $-637,324 | $-3,627,535 | $4,254,257 | $3,814,229 | $1,758,675 |
| EPS Basic Total Ops | -21.82 | -121.79 | 142.61 | 128.13 | 58.93 |
| EPS Basic Continuous Ops | -21.82 | -121.79 | 142.61 | 128.13 | 58.93 |
| EPS Diluted Total Ops | -21.82 | -121.79 | 140.83 | 126.47 | 58.27 |
| EPS Diluted Continuous Ops | -21.82 | -121.79 | 140.83 | 126.47 | 58.27 |
| EPS Diluted Before Non-Recurring Items | 11.78 | 14.42 | 15.66 | 10.52 | 7.06 |
| EBITDA(a) | $337,796 | $482,616 | $500,336 | $421,326 | $229,661 |